Chemical Compound
(1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-[1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one; [1R-(1a,2ss,3a,4a,4aa,11bss)]-1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-[1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one; (+)-Pancratistatin; NSC 349156; Pancratistatine
CAS Registry Number
96203-70-2
Primary record
(1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-[1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one; [1R-(1a,2ss,3a,4a,4aa,11bss)]-1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-[1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one; (+)-Pancratistatin; NSC 349156; Pancratistatine
- 库存
- 4,467 克
- 纯度
- 98.3 %
- CAS
- 96203-70-2
化合物标识与属性
- CAS
- 96203-70-2
- PubChem CID
- 441597
- SMILES
- C1OC2=C(O1)C(=C3C(=C2)[C@@H]4[C@H]([C@@H]([C@@H]([C@H]([C@@H]4O)O)O)O)NC3=O)O
- Canonical SMILES
- O=C1N[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@@H]2c2cc3c(c(O)c21)OCO3
名称与同义词
- Pancratistatin
- Pancratistatine
- (+)-Pancratistatin
- 4GUM4B7K5B
- 96203-70-2
- UNII-4GUM4B7K5B
- RefChem:858462
- NSC-349156
- AC1L9BE4
- SCHEMBL93612
- MLS002701837
- NSC349156
- CHEBI:7906
- CHEMBL419335
- DTXSID501315881
- DTXSID601028168
- orb1983574
- SCHEMBL27959004
- VREZDOWOLGNDPW-ALTGWBOUSA-N
- VREZDOWOLGNDPW-VYLNOMTASA-N
- DTXCID501513752
- DTXCID601745764
- GLXC-02877
- NSC 349156
- ZINC4097654
- CID441597
- CID:441597
- SMP1_000217
- DA-56579
- NCI60_003105
- SID:134222620
- HY-102010
- J362.301G
- CS-0022453
- NS00126096
- (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one
- 96281-31-1
- B844009K070
- C08535
- C044997
- Q7130395
- (1,3)Dioxolo(4,5-j)phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R,2S,3S,4S,4aR,11bR)-
- (1,3)Dioxolo(4,5-j)phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R-(1alpha,2beta,3alpha,4alpha,4aalpha,11bbeta))-
- (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b
- (1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-Hexahydro-1,2,3,4,7-pentahydroxy(1,3)dioxolo(4,5-j)phenanthridin-6(2H)-one
- [1,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-,
- (1R)-1beta,2alpha,3beta,4beta,7-Pentahydroxy-1,2,3,4,4abeta,5,6,11balpha-octahydro[1,3]dioxolo[4,5-j]phenanthridine-6-one
- (1R)-2,3,4,4abeta,5,11balpha-Hexahydro-1beta,2alpha,3beta,4beta,7-pentahydroxy[1,3]dioxolo[4,5-j]phenanthridin-6(1H)-one
- (1R,2S,3S,4S,4aR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one
- (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-Pentahydroxy-1,3,4,4a,5,11b-hexahydro-9H-[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one
- (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-1H,2H,3H,4H,4aH,5H,6H,9H,11bH-[1,3]dioxolo[4,5-j]phenanthridin-6-one
- (1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-(1,3)dioxolo(4,5-j)phenanthridin-6-one
- (1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-[1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one; [1R-(1a,2ss,3a,4a,4aa,11bss)]-1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-[1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one; (+)-Pancratistatin; NSC 349156; Pancratistatine
- (1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-Hexahydro-1,2,3,4,7-pentahydroxy[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one
- [1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R,2S,3S,4S,4aR,11bR)-
- [1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, [1R-(1alpha,2beta,3alpha,4alpha,4aalpha,11bbeta)]-
- 1beta,2alpha,3beta,4beta,7-Pentahydroxy-1,2,3,4,4abeta,5,6,11balpha-octahydro[1,3]dioxolo[4,5-j]phenanthridine-6-one